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O-linked-N-acetylglucosamine (O-GlcNAc) has
emerged as a critical regulator of diverse cellular
processes, but its role in embryonic stem cells
(ESCs) and pluripotency has not been investigated.
Here we show that O-GlcNAcylation directly regu-
lates core components of the pluripotency network.
BlockingO-GlcNAcylation disrupts ESC self-renewal
and reprogramming of somatic cells to induced
pluripotent stem cells. The core reprogramming
factors Oct4 and Sox2 are O-GlcNAcylated in
ESCs, but the O-GlcNAc modification is rapidly
removed upon differentiation. O-GlcNAc modifica-
tion of threonine 228 in Oct4 regulates Oct4 tran-
scriptional activity and is important for inducing
many pluripotency-related genes, including Klf2,
Klf5, Nr5a2, Tbx3, and Tcl1. A T228A point mutation
that eliminates this O-GlcNAc modification reduces
the capacity of Oct4 to maintain ESC self-renewal
and reprogram somatic cells. Overall, our study
makes a direct connection betweenO-GlcNAcylation
of key regulatory transcription factors and the
activity of the pluripotency network.
INTRODUCTION
Pluripotent stemcells, including embryonic stemcells (ESCs) and
induced pluripotent stem cells (iPSCs), are promising sources for
regenerativemedicine because of their ability to differentiate into
all cell types represented in the three primary germ layers. In
particular, iPSCs, which can be derived from patient tissue,
have great potential to be used in patient-specific cell therapy.
However, the practical application of such cells remains a distant
goal becauseofour limitedunderstandingof themolecularmech-62 Cell Stem Cell 11, 62–74, July 6, 2012 ª2012 Elsevier Inc.anisms underlying pluripotency (Hanna et al., 2010; Ng and
Surani, 2011; Okita and Yamanaka, 2010; Patel and Yang, 2010).
O-GlcNAcylation is an O-b-glycosidic attachment of single
N-acetylglucosamine (GlcNAc) to serine and threonine residues
of nucleocytoplasmic proteins. Similar to phosphorylation, this
posttranslational modification rapidly cycles on and off hundreds
of protein substrates in response to diverse biological cues.
However, unlike phosphorylation, only two enzymes catalyze
the addition and removal of O-GlcNAc in mammals: O-GlcNAc
transferase (OGT) adds the modification and O-GlcNAcase
(OGA) removes it (Hanover et al., 2010; Hu et al., 2010; Love
et al., 2010; Zeidan and Hart, 2010). Several studies have shown
that O-GlcNAcylation controls diverse aspects of cellular physi-
ology, such as nutrient and growth factor sensing, cell cycle
progression, and stress response, by regulating protein function,
localization, and stability (Hanover et al., 2010; Hart and Cope-
land, 2010; Hart et al., 2007; Love et al., 2010). In particular,
O-GlcNAcylation adjusts protein function according to the nutri-
tional status of the cell (Zeidan and Hart, 2010).
Glucose/nutrient conditions in culture affect ESCmaintenance
and differentiation, but the underlying mechanisms are poorly
understood. In vitro development of early human and mouse
embryos is enhanced in glucose-deficient media (Conaghan
et al., 1993; Quinn, 1995) whereas addition of glucosamine
during in vitro maturation inhibits embryo development (Sutton-
McDowall et al., 2006). In addition, glucose levels during forma-
tion of embryoid bodies (EBs) influence their differentiation
propensity, with high glucose generating beating cardiac muscle
more efficiently and low glucose promoting neuronal lineages
(Mochizuki et al., 2011). Complete loss of Ogt function is lethal
to mouse ESCs (Shafi et al., 2000). EBs with elevated O-GlcNAc
levels, through treatment with glucosamine or OGA inhibitors,
have impaired differentiation into cardiac cells (Kim et al.,
2009). Together these studies suggest that O-GlcNAcylation
promotes ESC maintenance, and decreases inO-GlcNAcylation
may be required for ESC differentiation.
The transcription factors Oct4, Sox2, Klf4 (collectively termed
OSK), and Nanog are part of a core pluripotency network that
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factors used in reprogramming somatic cells to iPSCs (Ng and
Surani, 2011; Stadtfeld and Hochedlinger, 2010). Previous
studies have shown that Sox2 undergoes O-GlcNAcylation in
rat forebrain (Khidekel et al., 2004), and Oct4 interacts with Ogt
(Pardo et al., 2010; van den Berg et al., 2010) and may undergo
O-GlcNAcylation (Webster et al., 2009) in ESCs. These data
suggest that O-GlcNAc could directly affect core components
of the pluripotency network to functionally regulate pluripotency
and somatic cell reprogramming.
In the present study, we analyzed the role ofO-GlcNAc in ESC
maintenance and differentiation and in somatic cell reprogram-
ming. We found that blocking O-GlcNAcylation inhibited ESC
self-renewal and the efficiency of iPSC generation, whereas
increasingO-GlcNAcylationduringEB formation inhibitednormal
ESC differentiation. Moreover, we determined that Oct4 and
Sox2 are modified by O-GlcNAc in mouse ESCs and that
O-GlcNAc regulates their transcriptional activity. Our study re-
veals that O-GlcNAc controls pluripotency by directly regulating
transcriptional activities of core components of the pluripotency
network. These findings will expand our understanding of the
reprogramming process and pluripotency at a molecular level.
RESULTS
O-GlcNAc Regulates ESC Self-Renewal
and Differentiation and Somatic Cell Reprogramming
To investigate the role of O-GlcNAc in ESC maintenance, we
perturbed O-GlcNAcylation by using either short hairpin RNAs
(shRNAs) against Ogt (shOgt) or chemical inhibition of Oga. We
selected shOgts (Figures S1A–S1C available online) that achieve
incomplete knockdown and are doxycline inducible (Figure 1A)
because complete elimination of Ogt expression is lethal to
ESCs (Shafi et al., 2000). Dox-treated E14 tTS Tet-shOgt cells
(Tet-shOgt) exhibited reduced numbers of colonies compared
to control shRNA-expressing cells (Tet-shMock) in colony form-
ing assays with the majority of colonies staining negative for
alkaline phosphatase (AP), suggesting that Ogt affects both
ESC proliferation (via cell cycle regulation or apoptosis) and
self-renewal (Figures 1B, 1C, and S1D). O-GlcNAc levels can
also bemanipulated with chemicals. E14 ESCs that were treated
with either streptozocin (streptozotocin; STZ), which is known to
inhibit OGA via the production of a transition state analog (Tole-
man et al., 2006), or glucosamine exhibited elevated global levels
of O-GlcNAc (Figure S1E). During EB formation, the normal
increase in lineage-specific marker expression and concordant
decrease in pluripotency marker expression was hampered by
STZ and glucosamine treatment (Figures 1D and S1F). These
results suggest that O-GlcNAc also affects ESC differentiation.
We also investigated the role of O-GlcNAcylation in reprog-
ramming fibroblasts to iPSCs. Transduction of Oct4-promoter-
driven GFP MEFs (pOct4-GFP MEFs) with OSK transgenes
induced colonies with ESC colony-like morphology. Some of
them expressed GFP, a marker of endogenous Oct4 expression
in our system (Figure S1G). All GFP-positive colonies were also
positive for AP staining (Figures S1H and S1I). In GFP-positive
colonies, the expression of ESC-specific genes (Oct4, Sox2,
and Nanog) was comparable to that of mouse ESCs and the
transgene was nearly silenced (Figures S1J and S1K).In MEFs, treatment of shOgts reduced globalO-GlcNAc levels
(Figure 1E). Addition of shOgts during OSK-driven iPSC genera-
tion reduced reprogramming efficiency (Figure 1F), whereas
overexpression of human OGT in MEFs elevated global
O-GlcNAc levels (Figure 1G) and increased reprogramming effi-
ciency (Figure 1H). Low-glucose culturemedium reduces cellular
O-GlcNAc levels compared to high-glucose medium (Figure 1I),
and MEFs reprogrammed under low-glucose medium devel-
oped fewer iPSC colonies (Figure 1J). Collectively, these results
demonstrate that O-GlcNAcylation is important for somatic cell
reprogramming.
Core Components of the Pluripotency Network
Are Modified by O-GlcNAc in Undifferentiated ESCs
To investigate the molecular mechanism linking O-GlcNAcyla-
tion and pluripotency, we postulated that O-GlcNAcylation
directly controls core components of the pluripotency network.
To test this hypothesis, we initially determined whether OSK
and Nanog were modified by O-GlcNAcylation. O-GlcNAcylated
proteins have high affinity for succinylated wheat germ agglutinin
(sWGA) and are easily eluted by competition withGlcNAc. There-
fore, we pulled-down overexpressed Myc-tagged OSK and
Nanog with sWGA beads and eluted the bound proteins by
competition with GlcNAc in HEK293 cells. Western blot analyses
showed that OSK but not Nanog was clearly pulled down by
sWGA (Figure S2A). We also purified sWGA-bound proteins
from ESC lysates and probed for OSK and Nanog by western
blot. All endogenous OSK but not Nanog bound specifically to
sWGA in ESCs, and competition with GlcNAc completely elimi-
nated their binding to sWGA (Figure 2A).
Because sWGA binds terminal GlcNAc residues, we deter-
mined whether the OSK binding to sWGA was mediated by
O-GlcNAc. Removal of terminal O-linked glycosidic modifica-
tions by b-N-Acetyl-hexosaminidase (b-hex) (Gandy et al.,
2006) during sWGA pull-down reduced Oct4 and Sox2 binding
to sWGA (Figure 2B). However, removal of N-linked GlcNAc via
excess PNGase F (Gandy et al., 2006) did not affect Oct4 and
Sox2 binding to sWGA (Figure 2C). Thus sWGA-Oct4
and -Sox2 interactions are due primarily to O-GlcNAc on Oct4
and Sox2.
We reconfirmed the O-GlcNAcylation of Oct4 and Sox2 by
western blot with anti-O-GlcNAc (clone CTD110.6), which recog-
nizesO-GlcNAcylated serine and threonine residues (Figure 2D).
Endogenous Oct4 and Sox2 interacted with Ogt (Figure 2E), and
a portion of nuclear Ogt colocalized with Oct4 and Sox2 (Figures
S2B and S2C) in undifferentiated ESCs.
During ESC differentiation into EBs, O-GlcNAcylation levels of
Oct4 and Sox2 decreased rapidly. Oct4 O-GlcNAcylation levels
decreased rapidly by day one and were nearly undetectable by
day two, but total Oct4 protein levels remained unchanged
over the same period (Figures 2F–2H). As controls, Ogt and
Gapdh O-GlcNAcylation levels were not altered.
Mapping O-GlcNAcylation Sites on Oct4 and Sox2
To identify the O-GlcNAcylation site(s) in Oct4, we initially
selected four putative O-GlcNAcylation sites by using the
YinOYang prediction server. Surprisingly, replacement of all
four putative serine and threonine residues with alanine did not
weaken the interaction with sWGA in HEK293 cells (Figure S3A).Cell Stem Cell 11, 62–74, July 6, 2012 ª2012 Elsevier Inc. 63
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mutants of Oct4 and sWGA. Oct4-truncated mutants, lacking
transactivation domain 1 (TAD1) and TAD2, still bound to
sWGA, but Oct4 deletion mutants that lacked the POU homeo-
domain (POU-h) failed to bind to sWGA (Figures 3A and S3B).
The O-GlcNAcylation of the POU domain of Oct4 was recon-
firmed by western blot with anti-O-GlcNAc (Figure 3B) in
HEK293 cells. Therefore, we chose to mutate additional putative
O-GlcNAcylation sites within the POU-h. Threonine 228 (T228)
and serine 229 (S229) were chosen because S229 has been
identified as a phosphorylation site in the ESC phosphopro-
teome (Swaney et al., 2009) and becauseO-GlcNAcylation often
competes with phosphorylation at the same or adjacent
residues. Replacement of putative serine and threonine residues
with alanine (T228A and S229A) reduced the Oct4 O-GlcNAc
level (Figure S3C). To determine whether these mutations also
reduce Oct4 O-GlcNAcylation in undifferentiated ESCs, we
stably expressed wild-type (WT) and point mutants of Flag-
tagged Oct4 into E14 cells. Although the undifferentiated state
of ESCs is sensitive to Oct4 levels (Niwa et al., 2000), slight
overexpression of Oct4 in our experiments maintained ESCs in
an undifferentiated state (Figures S3D and S3E). Through
western blot analyses, we determined that both T228A and
S229A reduced Oct4 O-GlcNAc levels in ESCs (Figure 3C).
To directly detect O-GlcNAc on Oct4 in ESC, we purified
O-GlcNAcylated Oct4 from ZHBTc4 F-Oct4 cells, which express
Flag-tagged Oct4 instead of endogenous Oct4 (van den Berg
et al., 2010), by serial pull-down with anti-Flag and sWGA.
Purified protein was analyzed by nano-LC-ESI-MS/MS.
O-GlcNAc on T228 was detected from three independent exper-
iments in succession (Figure 3D). Of note, Oct4 T228 residues
are highly conserved between species and among POU family
members (Figures S3F and S3G).
The O-GlcNAcylation sequence in Sox2 has been previously
determined in rat brain (Khidekel et al., 2004), although the exact
sites have not been identified (Figure S3H). We mutated all nine
serine and threonine sites in this sequence to alanine. By using
the sWGA binding assay and western blots with anti-O-GlcNAc
(CTD110.6), we identified S248, T258, and S259 as O-GlcNAcy-
lation sites (Figures S3I and S3J). To determine whether theseFigure 1. O-GlcNAc Regulates ESC Self-Renewal and Differentiation a
(A) Western blot showing reduced overall O-GlcNAc levels in E14 tTS Tet-shOgt c
detected by western blot with O-GlcNAc-specific antibody (CTD110.6).
(B and C) Mild knockdown of Ogt reduced ESC self-renewal capacity. E14 tT
undifferentiated state was assessed by alkaline phosphatase (AP) staining. Colo
(D) Enhancement ofO-GlcNAcylation perturbs ESC differentiation. E14 cells were
mRNA expression levels of lineage-specific markers and pluripotency markers
expressed as mean ± standard deviation (nR 3).
(E) Reduction in overall O-GlcNAc level by shRNA-mediated knockdown of Ogt
(F) Decrease in O-GlcNAc level reduces the efficiency of reprogramming. pOct4-
and Klf4 (OSK) in the presence of shOgts. Reprogrammed cells were detected b
presented (n = 3).
(G) Elevation in overall O-GlcNAc level by overexpression of human OGT in MEF
(H) Increase in O-GlcNAc level elevates the efficiency of reprogramming. MEFs w
colonies was presented (n = 3).
(I) Gradual increase in overall O-GlcNAc level by increasing glucose concentratio
(J) Reprogramming efficiency is increased in high-glucose media. pOct4-GFP M
GFP-positive colonies was presented (n = 3).
See also Figure S1.three sites are responsible for O-GlcNAcylation in undifferenti-
ated ESCs, we stably expressed Flag-tagged Sox2 WT and
mutant (S248A, T258A, and S259A) into E14 cells. Slight overex-
pression of Sox2 in our experiments maintained ESCs in an
undifferentiated state (Figure S3K). The triple mutant exhibited
reduced binding to sWGA in ESCs (Figure S3L). Recently, both
S248 and T258 were also identified asO-GlcNAcylated residues
in Sox2 by ETD MS/MS in ESCs (Myers et al., 2011), which is
consistent with our results.
An O-GlcNAcylation-Defective Mutant of Oct4 Reduces
Reprogramming Efficiency and ESC Self-Renewal
Having determined the O-GlcNAcylation sites in Oct4 and Sox2,
we next determined the effects of O-GlcNAc on Oct4 and Sox2
function. During OSK-driven reprogramming of pOct4-GFP
MEFs, we replacedwild-typeOct4 and Sox2with theirO-GlcNA-
cylation-defective point mutants. Substitution of Oct4 WT with
T228A inhibited the development of GFP-positive colonies,
with less than 5% GFP-positive colonies compared to Oct4
WT (Figures 4A and S4A). We also examined the effect of S229
phosphorylation on reprogramming, because S229 has been
previously identified as a phosphorylation site (Swaney et al.,
2009). Substitution of Oct4 WT with S229D (replacement of
serine 229 to aspartate), which mimics phosphorylation,
completely blocked the induction of GFP-positive colonies
(Figures 4A and S4A). Oct4 S229A, which cannot undergo
phosphorylation, had a milder effect inducing 30% GFP-
positive colonies compared to Oct4 WT. These differences in
reprogramming efficiency were not caused by disparities in viral
titer (Figures S4B–S4E). These results demonstrate that
O-GlcNAcylation of Oct4 at T228 leads to an increase in Oct4
activity, whereas phosphorylation at S229 inhibits its function.
Substitution of Sox2 WT with the triple mutant (S248A, T258A,
and S259A) did not alter reprogramming efficiency. However,
expression of the Sox2 double mutant (T258A and S259A)
induced about half as many GFP-positive colonies compared
with Sox2 WT (Figures S4F and S4G). There were no disparities
in viral titer of Sox2 WT and mutants (Figures S4H–S4J). These
seemingly confusing results could be due to crosstalk between
phosphorylation and O-GlcNAcylation. Because Sox2 S248nd Somatic Cell Reprogramming
ells upon addition of Doxycycline (+/ Dox). O-GlcNAcylation of proteins was
S Tet-shOgt cells were plated for self-renewal assay with/without Dox. The
ny numbers are expressed as mean ± standard deviation (nR 3).
differentiated into embryoid bodies (EBs) with/without streptozocin (STZ). The
were analyzed by real-time qPCR. The relative mRNA expression levels are
in MEFs was determined by western blot.
GFP MEFs were reprogrammed by forced expression of retroviral Oct4, Sox2,
y AP staining and GFP expression. The number of GFP-positive colonies was
s was determined by western blot.
ere reprogrammed as (F) in the presence of OGT. The number of GFP-positive
n in MEFs was determined by western blot.
EFs were reprogrammed in various glucose concentrations. The number of
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Figure 2. Core Components of the Pluripotency Network Are Modified by O-GlcNAc in Undifferentiated ESCs
(A) Whole-cell lysates from E14 cells were incubated with succinylated wheat germ agglutinin (sWGA)-conjugated agarose beads with/without N-acetyl-
D-glucosamine (GlcNAc, 0.5 M). Bound proteins were analyzed by western blot.
(B and C) During sWGA pull-down assay, sWGA-bound proteins were treated with b-N-Acetyl-hexosaminidase (b-hex) or PNGase F.
(D) Whole-cell lysates from E14 cells were immunoprecipitated with antibodies for Oct4 or Sox2.O-GlcNAcylation of proteins was detected by western blot with
O-GlcNAc-specific antibody (CTD110.6). Specificity of the antibody was checked by competition with GlcNAc.
(E) Endogenous interactions between Ogt and Oct4 or between Ogt and Sox2 in E14 cells were detected by coimmunoprecipitation assay.
(F) Changes in protein levels of OSK and Ogt during ESC differentiation into EBs were assessed by western blot. Gapdh level was measured as a control.
(G and H) O-GlcNAcylation levels of Oct4 and Sox2 decrease during ESC differentiation into EBs. Whole-cell lysates from E14 EBs were pulled down with
sWGA-agarose. Bound proteins were analyzed by western blot. Relative percent of total Oct4 and Sox2, and sWGA-bound Oct4 and Sox2 levels are expressed
as mean ± standard deviation (nR 3). Ogt and Gapdh O-GlcNAc levels were measured as controls.
See also Figure S2.
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S3J; Myers et al., 2011) and phosphorylation (Rigbolt et al.,
2011; Swaney et al., 2009), O-GlcNAc and phosphate may66 Cell Stem Cell 11, 62–74, July 6, 2012 ª2012 Elsevier Inc.compete with each other at this site. S248A blocks both phos-
phorylation and O-GlcNAcylation, so if one of these modifica-
tions severely reduces Sox2 activity, S248A may increase
A B C
D
Figure 3. Mapping O-GlcNAcylation Sites on Oct4
(A) POU domain of Oct4 undergoesO-GlcNAcylation. Whole-cell lysates fromHEK293 cells overexpressing various truncationmutants of Oct4 were pulled down
with sWGA-agarose. Bound proteins were eluted by competition with 0.5 MGlcNAc and analyzed by western blot. The results are summarized and presented as
schematics.
(B)Whole-cell lysates fromHEK293 cells overexpressing HA-tagged POU domain of Oct4 were immunoprecipitated with anti-HA.O-GlcNAcylation of the protein
was detected by western blot with O-GlcNAc antibody (CTD110.6). Specificity of the antibody was checked by competition with GlcNAc.
(C)Whole-cell lysates from E14 cells expressing Flag-Oct4WT and point mutants were immunoprecipitated with anti-Flag.O-GlcNAcylation of Oct4 proteins was
detected by western blot with O-GlcNAc antibody (CTD110.6). Asterisk indicates IgG heavy chain.
(D) T228 on Oct4 is O-GlcNAcylated in ESCs. O-GlcNAcylated Oct4 was purified from ZHBTc4 F-Oct4 cells by immunoprecipitation with anti-Flag, and then
sWGA pull down. Purified Oct4 was analyzed by nano-LC-ESI-MS/MS. O-GlcNAcylation on Oct4 T228 was detected from three independent experiments.
See also Figure S3.
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S259A) represses Sox2 activity, all three mutations may cancel
out their effects on Sox2 function.
Since we determined that Oct4 O-GlcNAcylation at T228
reduces Oct4 activity during reprogramming, we next investi-
gated whether it affects ESC maintenance. We replaced endog-
enous Oct4 with O-GlcNAc-defective Oct4 using ZHBTc4 cells
(Niwa et al., 2000), which completely lose Oct4 protein within
24 hr after Dox addition (Lee et al., 2010). ZHBTc4 cells were
infected with Flag-Oct4 WT or mutants of equivalent viral titerand Dox was added 24 hr after infection. 8 days after Dox treat-
ment, approximately 100 colonies with undifferentiated ESC
morphology appeared in Flag-Oct4 WT-infected plates whereas
no colonies appeared in Flag-Mock-infected plates and only
a few colonies appeared in Flag-Oct4 T228A-infected plates
(Figures 4B and 4C), suggesting that Oct4 T228A is reduced in
its capacity to maintain ESCs compared to Oct4 WT.
Although rare, Flag-Oct4 T228A was capable of forming undif-
ferentiated colonies in infected ESCs. We attempted to examine
the undifferentiated colonies from Oct4 T228A cells but failedCell Stem Cell 11, 62–74, July 6, 2012 ª2012 Elsevier Inc. 67
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Figure 4. An O-GlcNAcylation-Defective
Mutant of Oct4 Reduces Reprogramming
Efficiency and ESC Self-Renewal
(A) During OSK-driven reprogramming of
pOct4-GFP MEFs, wild-type Oct4 was replaced
with various Oct4 point mutants. Reprogrammed
cells were identified by morphology, AP staining,
and GFP expression. Results from four indepen-
dent experiments are presented.
(B and C) Equal numbers of ZHBTc4 cells were
infected with same titer of retroviral Oct4 point
mutants. After selecting infected cells in the
presence of doxycycline (Dox) to eliminate
endogenous Oct4, ESC colonies were stained
with AP. AP-positive colony numbers are ex-
pressed as relative percent mean ± standard
deviation (n R 3).
(D) CAG promoter driven Flag-Oct4 WT and
T228A were introduced into ZHBTc4 cells in the
presence of Dox. After selecting Flag-Oct4 stably
expressing cells, cells were replated for self-
renewal assay. The undifferentiated state was
assessed by both morphology and AP staining.
Colony numbers are expressed as relative percent
mean ± standard deviation (n R 3).
See also Figure S4.
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long-term ESC culture (Pannell and Ellis, 2001). Therefore, we
stably expressed Flag-Oct4 WT and T228A under the control of
the constitutive CAG expression unit (Niwa et al., 1991, 2002) in
Dox-treated ZHBTc4 cells. Western blot analyses showed that
both Flag-Oct4 WT and T228 were expressed at comparable
levels and pluripotency markers (Nanog and Sox2) were also ex-
pressed similarly (Figure S4K). However Flag-Oct4 T228 cells
were prone to differentiate during culture. Colony-forming assays
showed that 50% of Flag-Oct4 T228 colonies were differenti-
ated (Figures 4D and S4L), thus showing that O-GlcNAc-defec-
tive Oct4 cannot promote self-renewal efficiently.
O-GlcNAcylation Regulates Oct4 Transcriptional
Activity
Next, we investigated themechanism bywhichO-GlcNAcylation
of Oct4 influences reprogramming and ESC self-renewal. Oct4
T228A showed no apparent difference in protein stability
compared to WT (Figure S5A). In addition, various Oct4 and
Sox2 mutants used in the reprogramming assay exhibited no
difference in cellular localization (Figures S5B–S5D).
To determine the effect ofO-GlcNAcylation on Oct4 transcrip-
tional activity, we used 103 Oct4 RE-luc, which contains ten
copies of the Oct4 response element (Oct4 RE) upstream of
the TATA box (Lee et al., 2005). To rule out the activity of endog-
enous Oct4, NIH 3T3 cells, which do not express Oct4 (Figures
5A), were stably incorporated with 103 Oct4 RE-luc. These
NIH 3T3 stable cells were infected with retroviral Oct4 WT and
mutants and luciferase activity was measured 4 days after infec-
tion. In this reporter assay, Oct4 T228A (TA) and S229D (SD)
barely activated luciferase expression, and S229A (SA) had68 Cell Stem Cell 11, 62–74, July 6, 2012 ª2012 Elsevier Inc.60% of WT activity (Figure 5A). Reporter activity of Oct4
mutants closely resembled their abilities to promote somatic
cell reprogramming (Figures 4A and 5A).
Oct4 and Sox2 cooperate in regulating many of their targets.
Therefore, we investigated the effect of O-GlcNAcylation on
Oct4 activity at promoters that are synergistically regulated by
Oct4 and Sox2. The reporter plasmid 63 O/S RE-luc, which
contains six copies of the Oct4 and Sox2 response elements
(O/S RE) upstream of the minimal Fgf4 promoter (Ambrosetti
et al., 2000), was used for this purpose. NIH 3T3 cells, which
have no endogenous Oct4 and Sox2 expression, were stably
incorporated with 63 O/S RE-luc. Expression of Oct4 or Sox2
alone slightly increased reporter activity, and simultaneous
expression of both synergistically increased reporter activity.
Oct4 TA and SD did not synergize with Sox2 to activate the
reporter gene (Figure S5E).
Next, we investigated the dependence of Oct4 activity on
O-GlcNAcylation by perturbing O-GlcNAcylation in our reporter
assay. Overexpression of human OGT in NIH 3T3 cells elevated
overall O-GlcNAc levels (Figure 5B). OGT overexpression
increased reporter activity in Oct4 WT-expressing cells but
not in Oct4 TA-expressing cells (Figure 5C). Elevating
O-GlcNAcylation with STZ also increased Oct4 WT-dependent
reporter activity (Figure S5F). Inhibition of O-GlcNAcylation
with shOgt (Figure 5D) reduced the Oct4-dependent, but not
constitutive MSCV promoter-dependent, reporter activity
(Figures 5E and S5G). Simultaneous infection of retroviral human
OGT with shOgts restored O-GlcNAc level and reporter activity
demonstrating that the changes in reporter activity were not
an off-target effect of shRNAs (Figures 5D and 5E). These
results suggest that O-GlcNAcylation of Oct4 enhances its
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p = 0.003
p = 0.006
p = 0.860
p < 0.01
p < 0.02
p = 0.013
p=0.006
Figure 5. O-GlcNAcylation Regulates Oct4 Transcriptional Activity
(A) Ten copies of Oct4-responsive element-driven luciferase (103 Oct4 RE-luc) reporter gene was stably incorporated into the genome of NIH 3T3 cells. These
stable cells, which have no endogenous Oct4, were infected with indicated retroviral Oct4 wild-type (WT) and mutants. Luciferase activity was measured 4 days
after infection with a luminometer. The values are expressed as relative percent mean luminescent units ± standard deviation (nR 3). TA and SA, T228A and
S229A; TA, T228A; SA, S229A; SD, S229D.
(B and C) Increasing O-GlcNAc by OGT overexpression elevates Oct4 WT, but not Oct4-TA, driven reporter activity. NIH 3T3 cells stably incorporated with 103
Oct4 RE-luc reporter gene were infected with retroviral Oct4 WT or TA. Then, overall O-GlcNAc level was increased by additional infection of retroviral Flag-
tagged OGT. Luciferase activity was measured 4 days after infecting OGT. p values shown.
(D and E) Decreasing O-GlcNAc by shOgts reduces Oct4-driven reporter activity. NIH 3T3 103 Oct4 RE-luc stable cells were infected with retroviral Oct4 WT.
Then, overall O-GlcNAc level was decreased by additional infection of retroviral shRNAs against Ogt. Luciferase activity was measured 4 days after infecting
shOgts. To check specific effect of shOgts, Flag-tagged human OGT was simultaneously infected with shOgts.
(F) E14 cells stably incorporated with 103 Oct4 RE-luc reporter gene were differentiated into EBs with/without STZ (3 mM). Luciferase activity was measured at
the indicated time points. At the same time, total Oct4 protein levels and O-GlcNAcylated Oct4 levels were determined by western blot and sWGA pull-down
assay.
(G) E14 cells stably incorporated with 103Oct4 RE-luc reporter gene were cultured in different glucose concentration. Luciferase activity wasmeasured1week
after culture. At the same time, total Oct4 protein levels and O-GlcNAcylated Oct4 levels were determined by western blot and sWGA pull-down assay.
See also Figure S5.
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Figure 6. Identification of Genes Regulated by Oct4 O-GlcNAcylation
(A) mRNA expression levels in E14 cells before differentiation (EB 0), 2 days after differentiation to EB (EB 2), and 2 days after differentiation to EB in the presence
of STZ (EB 2+ STZ) were analyzed by microarray. In addition, mRNA expression levels in ZHBTc4 cells treated with Dox for 24 hr in the presence (+D,STZ) or
absence (+D) of STZwere also analyzed bymicroarray. The probes (genes) were grouped according to the categories indicated and the number of probes (genes)
corresponding to the categories were represented with Venn diagrams. The genes in the selected category were compared with tentative Oct4 target genes from
published data (Sharov et al., 2008).
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site that controls Oct4 transcriptional activity.
Next, we wanted to see whether O-GlcNAcylation regulates
endogenous Oct4 transcriptional activity in ESCs. We stably
incorporated 103 Oct4 RE-luc reporter gene into the genome
of E14 cells or ZHBTc4 cells. During differentiation to EBs,
reporter activities of E14 103 Oct4 RE-luc stable cells sharply
decreased to less than 10% after 2 days of differentiation (Fig-
ure 5F). At that time point, total Oct4 protein levels remained
high but were almost depleted in O-GlcNAc (Figure 5F). STZ
partially recovered both the O-GlcNAc levels and reporter
activity (Figure 5F). Luciferase activity in ZHBTc4 103 Oct4
RE-luc stable cells was similarly decreased during differentiation
and restored by STZ (Figures S5H–S5J). However, STZ did not
increase reporter activity in the presence of Dox (Figure S5K),
suggesting that STZ induced reporter activity via O-GlcNAc-
Oct4. Reporter activities of E14 63 O/S RE-luc stable cells
also displayed a similar pattern (Figure S5L). E14 103 Oct4
RE-luc stable cells cultured in low-glucose (5.5 mM) media had
reduced O-GlcNAc-Oct4 level and reporter activity compared
to cells cultured in high-glucose (25 mM) media, despite
comparable levels of total Oct4 protein (Figure 5G). These results
demonstrate that the Oct4 activity is dependent on the
O-GlcNAcylation level of Oct4.
Identification of Genes Regulated by Oct4
O-GlcNAcylation
We next identified Oct4 target genes upregulated by O-GlcNA-
cylation of Oct4. Because O-GlcNAc levels of Oct4 are signifi-
cantly reduced after 2 days of differentiation to EBs without an
accompanying change in Oct4 protein levels (Figure 5F), we
postulated that expression ofO-GlcNAcylatedOct4 target genes
should be changed by this time point. In addition, because STZ
sustained O-GlcNAc levels on Oct4 during EB formation (Fig-
ure 5F), we postulated that the reduced expression of target
genes should be recovered by STZ. However, STZ-upregulated
genes may also include genes regulated by O-GlcNAcylation of
proteins other than Oct4. To rule out those genes, we used
ZHBTc4 cells, which lose Oct4 upon Dox treatment. Genes
whose expression levels were recovered from STZ addition in
Dox-treated ZHBTc4 cells may not be regulated by Oct4
O-GlcNAcylation, and so these genes were eliminated from our
subsequent analyses.
In mRNA microarray experiments (Table S1; raw data), 203
probes (174 genes; Table S2) among 12,222 validated probes
satisfied our criteria for potential O-GlcNAcylated Oct4 target
genes (Figure 6A, left). These 174 genes could represent both
direct and indirect targets of O-GlcNAcylated Oct4. To identify
the direct targets of O-GlcNAcylated Oct4, we chose a subset(B) Potential O-GlcNAcylated Oct4 target genes were presented with clustered i
(C) E14 cells were differentiated into EBs in the presence or absence of STZ. mRN
by real-time qPCR.
(D) O-GlcNAcylated Oct4-bound chromatins were purified by chromatin immuno
ZHBTc4 F-Oct4 cell chromatin. DNA fragments present in the purified chromatin w
analyzed.
(E) ChIP-seq binding profiles for some potential O-GlcNAcylated Oct4 target gen
(F) Refined tentative direct O-GlcNAcylated Oct4 target genes were presented.
See also Figure S6.of known Oct4 target genes among the list of validated probes.
Among 485 tentative Oct4 target genes (622 probes) from pub-
lished data (Sharov et al., 2008), 45 genes (57 probes) were
included inour set of potentialO-GlcNAcylatedOct4 target genes
(Figure 6A, right).We classified these 45 genes as potential genes
directly upregulated by O-GlcNAcylated Oct4 (Figure 6B and
Table S3). Using a similar logic, we found three potential genes
directly downregulated by O-GlcNAcylated Oct4 (Table S4).
We confirmed a subset of our microarray data by using real-
time qPCR. O-GlcNAcylated Oct4 targets selected from our
data set (Nanog, Klf4, Klf2, Esrrb, and Zfp42) were indeed
reduced in expression during ESC differentiation into EBs, and
their expression was also recovered upon addition of STZ. In
contrast, expression ofUtf1,which was not identified as a poten-
tial O-GlcNAcylated Oct4 target gene, was not reduced in day 2
EBs nor significantly affected by STZ treatment (Figure 6C). In
ZHBTc4 cells, addition of Dox nearly eliminated Oct4 protein,
and STZ did not affect expression of the putative targets
(Figure S6A).
If the selected genes are direct targets of O-GlcNAcylated
Oct4, their promoters should be occupied by O-GlcNAcylated
Oct4. Using serial chromatin immunoprecipitation (ChIP) and
sequencing, we tested whether O-GlcNAcylated Oct4 occupied
these potential target gene promoters. ZHBTc4 F-Oct4 cells
were ChIPed with Flag antibody. After eluting the bound
chromatin by competition with Flag peptide, eluates were
re-ChIPed by sWGA agarose. Bound chromatin was eluted by
competition with GlcNAc and sequenced with genome Analyzer
II. 485 tentative Oct4 target genes (Sharov et al., 2008) were
analyzed (Figure 6D and Table S5). Among 485 genes, 271 genes
showed ChIP-sequencing (ChIP-seq) signals in their gene region
(defined as 10 kb from transcription stat site to +10 kb from
transcription ending site). Among 45 potential O-GlcNAcylated
Oct4 target genes, 29 genes, including Klf2, Klf5, Nr5a2, Tbx3,
Tcl1, and Zfp42, showed ChIP-Seq signals in their gene region
(Figure 6E). A subset of these ChIP-Seq results was confirmed
by PCR (Figure S6B). We present these 29 genes as refined
tentative O-GlcNAcylated Oct4 target genes. Key regulators of
ESCs, such as Klf2, Klf5, Nr5a2, Tbx3, and Tcl1, are included
in the list (Figure 6F).
DISCUSSION
In this study, we demonstrate that O-GlcNAc is an important
regulator of pluripotency. O-GlcNAc is critical for ESC self-
renewal and somatic cell reprogramming to pluripotency. Mild
knockdown of Ogt reduces ESC potential to self-renew (Figures
1A–1C). Increasing global O-GlcNAc levels by glucosamine
or STZ inhibits normal ESC differentiation (Figures 1D andmages.
A levels of selected putativeO-GlcNAcylated Oct4 target genes were analyzed
precipitation (ChIP) assays with anti-Flag, and then re-ChIPed with sWGA from
ere sequenced with genome Analyzer II. 485 tentative Oct4 target genes were
es.
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Figure 7. A Model Directly Linking O-GlcNAc with Pluripotency
Ogt adds O-GlcNAc on Oct4 and Sox2, the core components of pluripotency
network in ESCs. O-GlcNAc on Oct4 is important for the expression of
O-GlcNAcylated Oct4 target genes such as Klf2, Klf5, Nr5a2, Tbx3, and Tcl1,
which have all been implicated in the regulation of pluripotency.
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reprogramming efficiency of generating iPSCs (Figure 1F), and
increasing O-GlcNAc levels by OGT overexpression increased
reprogramming efficiency (Figure 1H). Together, these results
suggest that O-GlcNAc is important for both maintaining
and inducing pluripotency. We also demonstrate here that
O-GlcNAcylation is critical for Oct4 transcriptional activity and
that inhibition of Oct4 O-GlcNAcylation disrupts pluripotency.
O-GlcNAcylation of Oct4 is important for Oct4 to activate
many pluripotency-related genes such as Klf2, Klf5, Nr5a2,
Tbx3, and Tcl1 (Figure 7).
ESCs are commonly cultured in high-glucose (25 mM) media,
and the restriction of nutrients such as glucose and amino acids
is a basic strategy employed in the in vitro differentiation of ESCs
(Mochizuki et al., 2011). BecauseO-GlcNAc signaling is sensitive
to nutrient status, we hypothesized that nutrient status may
affect pluripotency and differentiation via O-GlcNAcylation. In
accordance with this idea, we found that reprogramming is
inefficient under low-glucose (5.5 mM) conditions compared to
high-glucose conditions (Figure 1J).
The threonine 228 residue on Oct4 undergoes O-GlcNAcyla-
tion, and T228-O-GlcNAc increased Oct4 activity (Figures 3, 4,
and 5). We could not detect O-GlcNAc at Oct4 serine 229 via
mass spectroscopy, although Oct4 S229A was reduced in
O-GlcNAc level (Figure 3C). This does not completely eliminate
the possibility that S229 is also O-GlcNAcylated, but the effect
of S229A is much milder than that of T228A (Figures 4 and 5).
The double alanine mutant of Oct4 at T228 and S229 was not
completely depleted in O-GlcNAcylation (Figure 3C), leaving
the possibility that additional O-GlcNAcylation site(s) may exist.
However, we demonstrate that T228 is the major O-GlcNAcyla-
tion site that regulates Oct4 transcriptional activity. In contrast
to Oct4 WT, Oct4 T228A transcriptional activity was not affected
by perturbation of O-GlcNAc levels (Figure 5C).
Serine 229 on Oct4 has been identified as a phosphorylation
site (Swaney et al., 2009) and has been predicted to bemodified/
catalyzed by PKA (protein kinase A) through bioinformatic
analyses (Saxe et al., 2009). Oct4 S229D, which mimics phos-
phorylation, decreased Oct4 reporter activity. However, contra-
dictory results have been obtained by the same researchers with
treatment of a PKA activator, 8-Br-cAMP, which elevated both
Oct4 protein levels and reporter activity (Saxe et al., 2009).
ESCs treated with 8-Br-cAMP showed conflicting results with
ESC differentiation occurring in the presence of LIF, and ESC72 Cell Stem Cell 11, 62–74, July 6, 2012 ª2012 Elsevier Inc.self renewal maintained in the absence of LIF (Faherty et al.,
2007). Our results show that Oct4 S229D completely loses tran-
scriptional activity (Figures 5A and 5D) and cannot induce
reprogramming to iPSCs (Figures 4A and 4B). Considering that
Oct4 S229A retains 50% of WT transcriptional activity (Fig-
ure 5A) and 30% of WT ability to induce iPSCs (Figure 4A),
Oct4 S229D may faithfully mimic phosphorylation. Although it
is clear that phosphorylation at S229 negatively regulates Oct4
activity, the kinase(s) responsible for the modification is (are)
not apparent yet.
Using microarray, we identified potential target genes that are
dominantly regulated by O-GlcNAcylated Oct4. To select direct
target genes, we used serial ChIP assay to purify Oct4 and then
the O-GlcNAcylated protein-bound DNA. Several pluripotency-
related factors, such as Klf2, Klf5, Nr5a2, Tbx3, and Tcl1, are
identified as direct targets. Among them, Klf2 and Klf5 can repro-
gramMEFs in conjunction with Oct4 and Sox2 (Nakagawa et al.,
2008) and sustain ESC self-renewal (Hall et al., 2009). Nr5a2 can
replace Oct4 (Heng et al., 2010) in the reprogramming process
and Tbx3 improves the germline competency of iPSCs (Han
et al., 2010). By regulating the expression levels of these genes,
O-GlcNAc of Oct4 may adjust the pluripotent state according to
the external signals.
Polycomb group (PcG) complexes have been suggested to
link O-GlcNAc cycling to epigenetic regulation of chromatin
and ESC differentiation (Love et al., 2010). PcG complexes set
the stage in ESCs for the acquisition andmaintenance of specific
developmental gene expression programs during development.
PcG complexes are essential for establishment of bivalent chro-
matin, which carry both active and repressive histone marks and
are a characteristic of ESCs (Sauvageau and Sauvageau, 2010;
Surface et al., 2010). OGT is a component of PcG complexes,
and its activity is essential for full repression by PcG (Gambetta
et al., 2009). Thus, OGT may regulate ESC differentiation in part
through PcG complexes. However, PcG complexes are not
required for the maintenance of self-renewal in ESCs (Sauva-
geau and Sauvageau, 2010; Surface et al., 2010) and cannot
sufficiently account for the critical role of O-GlcNAc in ESC
self-renewal.
In this study, we reveal thatO-GlcNAc regulates the function of
Oct4 and Sox2, which are core components of the pluripotency
network. In undifferentiated ESCs, Oct4 is O-GlcNAcylated
and upregulates several genes critical for maintenance of ESC
identity. Upon differentiation, O-GlcNAc is rapidly detached
from Oct4 and the expression of pluripotency-related Oct4
target genes is decreased. These findings may explain why
O-GlcNAc is critical for pluripotency.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and pOct4-GFP mice (Jackson Laboratory) used for mouse embry-
onic fibroblasts (MEFs) preparation were maintained as described (Cho
et al., 2010). Animal experimental procedures were approved by Institutional
Animal Care and Use Committee (IACUC) of Seoul National University, Korea
(SNU-070419-4).
Cell Culture
E14 mouse ESCs were cultured as described (Jang et al., 2009). ZHBTc4 cells
(Niwa et al., 2000) and ZHBTc4 F-Oct4 cells (van den Berg et al., 2010) were
Cell Stem Cell
Regulation of Pluripotency Network by O-GlcNAckindly provided by Hitoshi Niwa (RIKEN, Japan) and Raymond A. Poot (Eramus
MC, The Netherlands).
Doxycycline-Dependent Expression of shRNAs
Dox-dependent expression of shRNAs was done with Knockout Tet RNAi
System H (Clontech Laboratories, Inc.).
Self-Renewal Assay
Self-renewal assay (colony-forming assay) was done as described (Chambers
et al., 2007).
Reprogramming
Reprogramming was principally done per the Lim group (Han et al., 2010).
Mapping O-GlcNAcylation Sites via Nano-LC-ESI-MS/MS
Oct4 was purified by immunoprecipitation of lysates from 100 plates of 10 cm2
dishes of ZHBTc4 F-Oct4 cells with Flag antibody. After eluting bead-bound
Flag-Oct4 by competition with Flag peptide (Sigma), O-GlcNAcylated Oct4
was enriched by sWGA pull down. After SDS-PAGE and Colloidal Blue Stain-
ing (Invitrogen), Oct4 band was analyzed with nano-LC-ESI-MS/MS (Diatech
Korea., Co. LTD).
Microarray
Total RNAs from E14 and ZHBTc4 cells were extracted with TriZol (Invitrogen).
Microarray was performed by Macrogen (Korea) with Illumina MouseRef-8 v2
Expression BeadChip (Illumina, Inc., San Diego, CA).
ChIP Sequencing
ZHBTc4 F-Oct4 cells were ChIPed with Flag antibody. After eluting Flag-Oct4-
bound chromatins by competition with Flag peptide (Sigma), the eluates were
re-ChIPed with sWGA beads or agarose beads as a control. Sequencing and
analysis of ChIPed DNAs were performed by KRIBB (Korean Research Insti-
tute of Bioscience & Biotechnology) via genome Analyzer II.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE36322 and the ChIP-seq data have the accession number GSE36388.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and five tables and can be found with this article online at
doi:10.1016/j.stem.2012.03.001.
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